JMP Securities analyst Jason Butler downgrades Minerva Neurosciences (NASDAQ:NERV) from Market Outperform to Market Perform.
Dow Surges 500 Points; Johnson & Johnson Lowers Guidance
U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 500 points on Tuesday.